ST
BIIB icon

Somerset Trust’s Biogen BIIB Stock Holding History

Somerset Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-140
Closed -$33K – 111
2019
Q1 		$33K Buy
140
+84
+150% +$26.5K 0.02% 144
2018
Q4 		$17K Buy
56
+48
+600% +$15.3K 0.01% 125
2018
Q3 		$3K Buy
+8
New +$2.75K ﹤0.01% 126
2017
Q2 		– Sell
-12
Closed -$3K – 142
2017
Q1 		$3K Buy
+12
New +$3.39K ﹤0.01% 169

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Somerset Trust's BIIB Position: Q2 2019 in Review

Somerset Trust sold out of Biogen (BIIB) in Q2 2019, closing a stake of 140 shares — an estimated $33K sold.

Somerset Trust first reported a position in BIIB in Q1 2017 and held it in 4 quarters. The position peaked at $33K in Q1 2019. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Somerset Trust reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Somerset Trust sold 140 Biogen shares in Q2 2019, an estimated $33K.
  • Somerset Trust first reported a position in Biogen in Q1 2017 and held it in 4 quarters.
  • Somerset Trust's Biogen position peaked at $33K in Q1 2019.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Somerset Trust's 13F filing for Q2 2019, filed 31 Jul 2019.